How is the CureVac N.V. today?

The CureVac N.V. today is trading in the green, up by 3.58% at 4.63.

What is CureVac N.V. Annual Revenue?

CureVac N.V. Annual Revenue rose 895.54%, in the last year to $535.18 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is CureVac N.V. Annual Net Profit?

CureVac N.V. Annual Net Profit rose 162.34% in the last year to $162.19 M. Its sector's average net profit growth for the last fiscal year was -12.66%.

What is CureVac N.V. Price to Earning Ratio?

CureVac N.V. Price to Earning Ratio is 5.08, higher than its sector PE ratio of 4.39.

What is CureVac N.V. Stock Price?

CureVac N.V. Stock Price rose 19.02% and underperformed its sector by 19.57% in the past year.

What is CureVac N.V. Quarterly Revenue?

CureVac N.V. Quarterly Revenue fell 92.78% YoY to $0.89 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is CureVac N.V. Quarterly Net profit?

CureVac N.V. Quarterly Net profit rose 26.18% YoY to $52.08 M. Its sector's average net profit growth YoY for the quarter was -235.97%.

What is CureVac N.V. Debt to Equity Ratio?

CureVac N.V. Debt to Equity Ratio of 0.06 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is CureVac N.V. Return on Equity(ROE)?

CureVac N.V. Return on Equity(ROE) for the last financial year was 26.73%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is CureVac N.V. Mutual Fund Holding?

CureVac N.V. Mutual Fund Holding increased by 0.01% in the last quarter to 2.3.

What is CureVac N.V. Institutional Holding?

CureVac N.V. Institutional Holding decreased by 0.15% in the last quarter to 4.13.

CureVac N.V. XNAS: CVAC

CureVac N.V. Live Share Price Today, Share Analysis and Chart

Name: CureVac N.V.: Is Infosys Ltd. worth buying?
Item: CureVac N.V.
Rating: 3.61600
Author: Trendlyne DVM scores

about

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboratio...

4.63 0.16 (3.58%)

95.36% Gain from 52W Low

980.8K XNAS Volume

XNAS 02 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Affordable Valuation

72.0 / 100

Technically Bullish

72.6 / 100

6

1Yr Price target upside is 37%

6 analysts

CureVac N.V. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

CureVac N.V. FAQ

How is CureVac N.V. today?

CureVac N.V. today is trading in the green, and is up by 3.58% at 4.63.

How has CureVac N.V. performed historically?

CureVac N.V. is currently trading up 3.58% on an intraday basis. In the past week the stock rose 13.20%. stock has been up 49.35% in the past quarter and rose 19.02% in the past year. You can view this in the overview section.